N
Nirmal Raut
Publications - 12
Citations - 233
Nirmal Raut is an academic researcher. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 3, co-authored 3 publications receiving 190 citations.
Papers
More filters
Journal ArticleDOI
Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience
Vanita Noronha,Rajesh Dikshit,Nirmal Raut,Amit Joshi,C S Pramesh,K George,J.P. Agarwal,Anusheel Munshi,Kumar Prabhash +8 more
TL;DR: Considerably higher numbers of Indian patients with lung cancer are non-smokers, compared to the West, and the global trend of rise in adenocarcinoma is paralleled in India.
Journal ArticleDOI
Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Rakesh Jalali,Nirmal Raut,Brijesh Arora,Tejpal Gupta,Debnarayan Dutta,Anusheel Munshi,Rajiv Sarin,Purna Kurkure +7 more
TL;DR: In this article, a prospective study of RT with concurrent and adjuvant temozolomide (TMZ) in children with diffuse intrinsic pontine gliomas (DIPGs) was presented.
Journal ArticleDOI
Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
Jayant Sastri Goda,Debnarayan Dutta,Nirmal Raut,Shashikant Juvekar,Nilendu Purandare,Venkatesh Rangarajan,Brijesh Arora,Tejpal Gupta,Purna Kurkure,Rakesh Jalali +9 more
TL;DR: Cumulative RPI was able to classify tumours into different grades and predicted clinical outcome and at baseline, MR hyperperfusion indicated a shorter survival for DIPG patients.
Journal ArticleDOI
Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in India
Aju Mathew,Serena Joseph,Jeffrey Mathew Boby,S. Benny,Janeesh Sekkath Veedu,Senthil Rajappa,Nitesh Rohatgi,Bhawna Sirohi,Reetu Jain,Vivek Agarwala,Deepak Kumar Shukla,A Mehta,Raja Pramanik,Vineet Talwar,Vinayak V Maka,Nirmal Raut +15 more
TL;DR: The proportion of patients with advanced cancer in India who received targeted therapy for an actionable genetic alteration identified on CGP assays was described, observing that in a low-middle–income country setting, only 4% of patients who underwent CGP testing obtained a clinical benefit.
Journal ArticleDOI
Comprehensive plasma genotyping reveals mutational signatures that confer resistance to tyrosine kinase inhibitors (TKI) in patients with advanced lung cancer.
Atul Bharde,Vichitra Behel,M. Bhonde,Chirantan Bose,Nirmal Raut,Alain D'Souza,Bhagwat Jadhav,Sangeeta Prajapati,Trupti Kad,Sujit Joshi,Vikas Jadhav,Kanchan Hariramani,Fauzul Mobeen,Aravindan Vasudevan,Mohan Uttarwar,Jayant Khandare,Kumar Prabhash,Gowhar Shafi +17 more
TL;DR: In this paper , a comprehensive gene panel for detecting actionable mutations and novel alterations from advanced lung cancer patients is presented. But, the authors do not discuss the clinical utility of their panel.